CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION

This adverse event was reported 209 times

These drugs are most commonly taken by patients reporting CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION:

# Drug Count
0 FLUDARABINE PHOSPHATE 58
1 CYCLOPHOSPHAMIDE 56
2 CYCLOPHOSPHAMIDE FOR INJECTION 56
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 56
4 RITUXIMAB 54
5 IBRUTINIB 36
6 VENETOCLAX 32
7 ALEMTUZUMAB 20
8 ALLOPURINOL 19
9 PREDNISOLONE 18
See all common drugs associated with CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION

CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CHLORAMBUCIL 8 0.0020
1 PENTOSTATIN 2 0.0019
2 MITOXANTRONE HYDROCHLORIDE 10 0.0016
3 FLUDARABINE PHOSPHATE 58 0.0015
4 AMINOCAPROIC ACID 1 0.0012
5 ALEMTUZUMAB 20 0.0010
6 IDELALISIB 7 0.0010
7 PROCHLORPERAZINE EDISYLATE 1 0.0008
8 ACYCLOVIR SODIUM 1 0.0008
9 CLADRIBINE 7 0.0007
See all drugs enriched for association with CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION

CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD52-directed Cytolytic Antibody [EPC] 20 0.0010
1 BCL-2 Inhibitor [EPC] 32 0.0005
2 Sulfonamide Antibacterial [EPC] 1 0.0003
3 Alkylating Drug [EPC] 57 0.0002
4 Thrombopoietin Receptor Agonist [EPC] 3 0.0002
5 CD20-directed Cytolytic Antibody [EPC] 59 0.0002
6 Echinocandin Antifungal [EPC] 1 0.0001
7 Vitamin K [EPC] 1 0.0001
8 Xanthine Oxidase Inhibitor [EPC] 19 0.0001
9 Antifibrinolytic Agent [EPC] 1 0.0001
See all drug classes enriched for association with CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION